Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.7B | 4.0B | 4.0B | 4.0B |
Cost of revenue | 2.1B | 2.3B | 2.3B | 2.2B |
Gross profit | 1.6B | 1.7B | 1.7B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.1B | 1.1B | 1.0B | 1.1B |
Other operating expenses | — | — | — | — |
Operating income | 584.8M | 686.1M | 712.2M | 669.1M |
Non operating interest income | ||||
Income | 14.3M | 17.5M | 16M | 1.4M |
Expense | 72.6M | 79.2M | 86.4M | 80.2M |
Other income expense | -16.5M | -90.1M | 345.5M | 400K |
Pretax income | 510M | 534.3M | 987.3M | 590.7M |
Tax provision | 103.5M | 54.8M | 246.5M | 95.7M |
Net income | 406.5M | 479.5M | 740.8M | 495M |
Basic EPS | 1.4 | 1.7 | 2.6 | 1.7 |
Diluted EPS | 1.4 | 1.7 | 2.6 | 1.7 |
Basic average shares | 283.4M | 283.3M | 283.6M | 284.6M |
Diluted average shares | 285.3M | 285.7M | 286M | 287M |
EBITDA | 848.2M | 952.3M | 971.2M | 918.1M |
Net income from continuing op. | 406.5M | 479.5M | 740.8M | 495M |
Minority interests | -4M | -6.6M | -4.3M | -4.1M |
Preferred stock dividends | — | — | — | — |